Qualité de vie des malades atteints de schizophrénie : étude de 100 cas Quality of life in patients with schizophrenia: A study of 100 cases

Summary Objective. — The aim of the present study was to evaluate the quality of life (QOL) in outpatients with schizophrenia, and to identify factors correlated to an impaired QOL among them. Subjects and methods. — A transversal study, in the form of an inquiry, was conducted in 100 outpatients, during seven months, in the psychiatric department of the Hedi Chaker teaching hospital in Sfax — Tunisia. We used the ‘‘36 item Short-Form Health Survey’’ (SF-36) to assess the QOL; this has been considered as impaired when the global medium score was inferior to

[1]  J. Guelfi,et al.  Évaluation comparative de la qualité de vie de patients schizophrènes traités par neuroleptiques classiques et neuroleptiques atypiques : résultats d’une étude transversale , 2006 .

[2]  F. Limosin,et al.  Épidémiologie des troubles schizophréniques , 2006 .

[3]  A. Loundou,et al.  Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments , 2005, European Psychiatry.

[4]  T. Shibre,et al.  Short-term symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia , 2005, Schizophrenia Research.

[5]  W. Fleischhacker,et al.  Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. , 2005, The British journal of psychiatry : the journal of mental science.

[6]  J. Newcomer,et al.  Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients , 2004, Schizophrenia Research.

[7]  Hok Pan Yuen,et al.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features , 2004, Schizophrenia Research.

[8]  H. Möller,et al.  Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression , 2003, Psychiatry Research.

[9]  Y. Kaneda.  The Impact of Prolactin Elevation With Antipsychotic Medications on Subjective Quality of Life in Patients With Schizophrenia , 2003, Clinical neuropharmacology.

[10]  Y. Kaneda,et al.  Quetiapine Impact on Quality of Life in Patients with Schizophrenia* , 2003, The Annals of pharmacotherapy.

[11]  C. Lançon,et al.  Revue critique des instruments de mesure de la qualité de vie dans la schizophrénie , 2000 .

[12]  C. Mercier,et al.  An evaluation of psychometric properties of the client's questionnaire of the Wisconsin Quality of Life Index-Canadian version (CaW-QLI) , 1999, Quality of Life Research.

[13]  N C Andreasen,et al.  Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. , 1998, The American journal of psychiatry.

[14]  F. Dickerson,et al.  Subjective quality of life in out‐patients with schizophrenia: clinical and utilization correlates , 1998, Acta psychiatrica Scandinavica.

[15]  F. Dickerson,et al.  Neurocognitive deficits and social functioning in outpatients with schizophrenia , 1996, Schizophrenia Research.

[16]  A. Lane,et al.  Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia , 1996, Acta psychiatrica Scandinavica.

[17]  D. Braff,et al.  Gender differences on thought disturbance measures among schizophrenic patients. , 1995, The American journal of psychiatry.

[18]  Barbara Gandek,et al.  The SF-36 Health Survey: Development and use in mental-health research and the IQOLA project , 1994 .